The results revealed that immRNA‐loaded RBCEVs treatment activated the RIG‐I pathway by up‐regulating DDX58, MDA5, RSAD2, MAVS, IRF3, IRF7, IFNB, and ISG56 in the tumour cells (Figure S4G). This evidence concerns the gene MAVS and neoplasm.